Yukin Therapeutics

About:

Yukin Therapeutics specializes in the development of new molecules for the treatment of cancer.

Website: https://www.yukintx.com/

Top Investors: Medicxi, AdBio partners

Description:

Yukin Therapeutics is a French biotechnology company. The company focuses on the development of new therapeutic molecules, entitled kinase inhibitors, specifically targeting a protein involved in the development of several types of cancer: the NIK protein (NF-κB inducing kinase). Yukin Therapeutics led studies that demonstrated proof of concept in animal models and is now actively seeking to identify a first drug candidate to launch a clinical trial in oncology.